Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a biopharmaceutical company developing and manufacturing innovative monoclonal antibodies for the treatment of cancer and serious viral infections.
Thorpe Aug 7-11
...........................................................
International Meeting on Cellular Biology of Pathogens
When
07 - 10 Aug-11
Where
Sofitel, Sao Paulo, Brazil
Categories
Medical & Pharmaceutical
Conference Description:
International Meeting on Cellular Biology of Pathogen would provide an abundant opportunity to the biochemists, structural biologists, cell biologists, physiologists, scientists and geneticists to interact with experts and share their innovative ideas and thoughts get the positive solutions which would be benefited for the industry. International Meeting on Cellular Biology of Pathogen would have speakers such as Dominique Soldati Favre, University of Geneva, Elizabetta Ullu, Yale University Scholl of MedicineJoão Luiz M. Wanderley, INCA, Jorge Galan, Yale University Scholl of Medicine, Maria Cristina Pessolani, Instituto Oswaldo Cruz, Michael Duszenko, University of Tuebingen, Nicolas Fasel, Université de Lausanne, Philip Thorpe, UT, Southwestern Medical Center, Robert Menard, Institute Pasteur etc
biztradeshows.com
Oct. 31, Nov. 2, 2011
Participating Companies at BIO-Europe® 2011
Peregrine Pharmaceuticals
ebdgroup.com
A new national initiative involving where volunteers can be matched to a scientific research project, or clinical trial, for which they might qualify.
Interested adult volunteers, parents or caregivers register on the ResearchMatch Web site (www.researchmatch.org) and indicate their interest in participating in research studies. Both healthy volunteers and those with specific medical conditions can sign up.
Message 26090452
CRISP has a new site for checking on grants.
projectreporter.nih.gov
Government link for definions used in trials.
prsinfo.clinicaltrials.gov
Patent office definitions:
uspto.gov |
